These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 28123247)

  • 1. Anterior segment changes on ultrasound biomicroscopy after intravitreal anti vascular endothelial growth factor injection.
    Trehan HS; Kaushik J; Rangi A; Parihar AS; Vashisht P; Parihar JK
    Med J Armed Forces India; 2017 Jan; 73(1):58-64. PubMed ID: 28123247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short term effects of intravitreal anti-vascular endothelial growth factor agents on cornea, anterior chamber, and intraocular pressure.
    Arslan GD; Guven D; Alkan AA; Kacar H; Demir M
    Cutan Ocul Toxicol; 2019 Dec; 38(4):344-348. PubMed ID: 31092017
    [No Abstract]   [Full Text] [Related]  

  • 3. [Structural changes in the ocular anterior segment against elevation of intraocular pressure after repeated intravitreal injections].
    Budzinskaya MV; Bubnova IA; Kurguzova AG; Fettser EI
    Vestn Oftalmol; 2018; 134(5. Vyp. 2):156-161. PubMed ID: 30499511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of prior glaucoma surgery on intraocular pressure immediately after anti-vascular endothelial growth factor injection.
    Lam J; Luttrell I; Ding L; Rezaei K; Chao JR; Chee Y; Olmos De Koo LC; Wen JC
    Graefes Arch Clin Exp Ophthalmol; 2019 Nov; 257(11):2489-2494. PubMed ID: 31388743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of Anti-Vascular Endothelial Growth Factor Agents on Intraocular Pressure and Glaucoma: A Report by the American Academy of Ophthalmology.
    Hoguet A; Chen PP; Junk AK; Mruthyunjaya P; Nouri-Mahdavi K; Radhakrishnan S; Takusagawa HL; Chen TC
    Ophthalmology; 2019 Apr; 126(4):611-622. PubMed ID: 30472176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraocular Pressure Changes in Non-Glaucomatous Patients Receiving Intravitreal Anti-Vascular Endothelial Growth Factor Agents.
    Kiddee W; Montriwet M
    PLoS One; 2015; 10(9):e0137833. PubMed ID: 26360382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of intravitreal injection of bevacizumab with or without anterior chamber paracentesis on intraocular pressure and peripapillary retinal nerve fiber layer thickness: a prospective study.
    Soheilian M; Karimi S; Montahae T; Nikkhah H; Mosavi SA
    Graefes Arch Clin Exp Ophthalmol; 2017 Sep; 255(9):1705-1712. PubMed ID: 28616715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term intraocular pressure changes immediately after intravitreal injections of anti-vascular endothelial growth factor agents.
    Kim JE; Mantravadi AV; Hur EY; Covert DJ
    Am J Ophthalmol; 2008 Dec; 146(6):930-4.e1. PubMed ID: 18775528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term changes of intraocular pressure and ocular perfusion pressure after intravitreal injection of bevacizumab or ranibizumab.
    Lee JW; Park H; Choi JH; Lee HJ; Moon SW; Kang JH; Kim YG
    BMC Ophthalmol; 2016 May; 16():69. PubMed ID: 27245159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes in intraocular pressure after intravitreal injections].
    Bubnova IA; Kurguzova AG
    Vestn Oftalmol; 2018; 134(4):47-51. PubMed ID: 30166510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DYNAMIC CHANGES OF THE ANTERIOR CHAMBER ANGLE PRODUCED BY INTRAVITREAL ANTI-VASCULAR GROWTH FACTOR INJECTIONS.
    Wen JC; Cousins SW; Schuman SG; Allingham RR
    Retina; 2016 Oct; 36(10):1874-81. PubMed ID: 26938953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term effects of intravitreal bevacizumab on cornea and anterior chamber.
    Güler M; Capkın M; Simşek A; Bilak S; Bilgin B; Hakim Reyhan A; Fırat M
    Curr Eye Res; 2014 Oct; 39(10):989-93. PubMed ID: 24588314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term effect on the ocular circulation induced by unilateral intravitreal injection of aflibercept in age-related maculopathy.
    Mursch-Edlmayr AS; Luft N; Podkowinski D; Ring M; Schmetterer L; Bolz M
    Acta Ophthalmol; 2019 Sep; 97(6):e927-e932. PubMed ID: 30916896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of sustained intraocular pressure elevation in eyes receiving intravitreal anti-vascular endothelial growth factor therapy.
    Yannuzzi NA; Patel SN; Bhavsar KV; Sugiguchi F; Freund KB
    Am J Ophthalmol; 2014 Aug; 158(2):319-327.e2. PubMed ID: 24814167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypotensive efficacy of topical brimonidine for intraocular pressure spikes following intravitreal injections of antivascular endothelial growth factor agents: a randomised crossover trial.
    Felfeli T; Hostovsky A; Trussart R; Yan P; Brent MH; Mandelcorn ED
    Br J Ophthalmol; 2019 Oct; 103(10):1388-1394. PubMed ID: 30573499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring intraocular pressure changes after intravitreal Ranibizumab injection using rebound tonometry.
    Fuest M; Kotliar K; Walter P; Plange N
    Ophthalmic Physiol Opt; 2014 Jul; 34(4):438-44. PubMed ID: 24731161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal Changes in Retinal Nerve Fiber Layer Thickness after Intravitreal Anti-vascular Endothelial Growth Factor Therapy.
    Jo YJ; Kim WJ; Shin IH; Kim JY
    Korean J Ophthalmol; 2016 Apr; 30(2):114-20. PubMed ID: 27051259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Features Associated with Acute Elevated Intraocular Pressure After Intravitreal Anti-VEGF Injections.
    LoBue SA; Gindina S; Saba NJ; Chang T; Davis MJ; Fish S
    Clin Ophthalmol; 2023; 17():1683-1690. PubMed ID: 37333491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of intraocular pressure change and anterior segment parameters after intravitreal bevacizumab injection - Cannula size matters.
    Hamidi NA; Güneş İB; Baykara M
    Saudi J Ophthalmol; 2020; 34(4):247-250. PubMed ID: 34527866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in anterior segment morphology after intravitreal injection of bevacizumab and bevacizumab-triamcinolone acetate combination.
    Alkin Z; Perente I; Altan C; Konstantinidis A; Ozkaya A; Yuksel K; Yazici AT; Demirok A
    Eur J Ophthalmol; 2013; 23(4):504-9. PubMed ID: 23640509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.